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Objective: Endovascular aneurysm repair (EVAR) is rapidly becoming the predominant technique for repair of abdominal
aortic aneurysms. Results from current studies, however, are conflicting on the effect of EVAR on renal function
compared with standard open repair. Furthermore, data for open repair in patients with baseline renal insufficiency
suggests worse outcomes, including renal function. This analysis compared the effects of open repair vs EVAR on renal
function in patients with baseline renal insufficiency.
Methods:We reviewed our records for patients with preoperative chronic renal insufficiency (serum creatinine, 1.5mg/dL)
who underwent open repair or EVAR between 1999 and 2004. The same group of vascular surgeons at a single
institution performed aneurysm repair on 98 patients: 46 open (37 men, 9 women) and 52 EVAR (50 men, 2 women).
Preoperative, postoperative, and follow-up serum creatinine and creatinine clearance were compared, as was the
development of postoperative renal impairment (increase in serum creatinine >30%).
Results: Serum creatinine and creatinine clearance were not statistically different between the open and EVAR groups
during any time period studied. Likewise when comparing the magnitude of change in serum creatinine in patients
between the postoperative and follow-up times with preoperative values, no significant differences existed between the
open and EVAR groups. When the change in serum creatinine over time within each group was compared, however, the
open group had a significant increase in serum creatinine postoperatively (2.43  1.20 vs 2.04  0.64, P  .012), which
returned to baseline during follow-up (1.96 0.94, P .504). Although serum creatinine in the EVAR group increased
compared with preoperative values of 2.04  0.55 (postoperative, 2.27  1.04; follow-up, 2.40  1.37), this failed to
reach statistical significance for the postoperative (P .092) or follow-up (P .081) periods. A similar pattern was noted
in creatinine clearance. Postoperative renal impairment was noted in 13 open (28%) and 15 EVAR patients (29%) and was
not statistically different between groups. Overall, two patients (4.3%) from the open group and four (7.7%) from the
EVAR group required hemodialysis; one in the EVAR group required permanent hemodialysis. This difference was not
statistically significant (P  .681).
Conclusions:Open and endovascular repair of abdominal aortic aneurysms in patients with pre-existent renal insufficiency
can be performed safely with preservation of renal function. In contrast to previous reports, no significant differences
existed between open repair and EVAR in postoperative alterations in renal function. Although a significant increase in
serum creatinine develops in patients with renal insufficiency postoperatively with open repair, this appears to be
transient, and preoperative renal dysfunction alone should not exclude either approach. After EVAR, patients with
pre-existing renal insufficiency continue to be at risk for progressive renal dysfunction, and protective measures should be
taken to preserve renal function in this patient population. (J Vasc Surg 2006;44:706-11.)Since the original description in 1991 by Parodi et al,1
endovascular aneurysm repair (EVAR) has become the
predominant method for treatment of infrarenal abdominal
aortic aneurysms. Despite recent prospective studies that
have demonstrated better outcomes after EVAR in the peri-
operative and intermediate time periods,2,3 concerns remain
about the long-term durability and safety of EVA R.4,5
One patient population at increased risk for perioperative
complications after open or endovascular repair are those with
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706baseline renal insufficiency.6 The effects of EVAR o n renal
function in these patients remains uncertain. Although
recent studies have shown that progressive renal dysfunc-
tion may develop in patients after EVAR, data are conflict-
ing about the effect of EVAR on renal function compared
with standard open repair.7,8 Furthermore, to our knowl-
edge, no study to date has compared the impact of EVAR
on renal function in patients with baseline renal insuffi-
ciency with those receiving standard open repair. The pur-
pose of this study is to compare the effects of open repair vs
EVAR on renal function in patients with pre-existent renal
insufficiency.
METHODS
Between August 1998 and September 2004, 98 pa-
tients with preoperative chronic renal insufficiency (serum
creatinine, 1.5 mg/dL) underwent open or endovascular
infrarenal abdominal aortic aneurysm repair. All patients
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ing at a single institution. Of these, 46 patients (37 men, 9
women) underwent open repair of an abdominal aortic
aneurysm. Five required a suprarenal cross clamp. All pa-
tients were treated by the same group of vascular surgeons
working at a single institution.
During this same period, 52 patients (50 men and 2
women) underwent aneurysm repair using endovascular
techniques. The endografts used were 3 Ancure (Guidant
Corp, Indianapolis, Ind), 6 AneuRx (Medtronic, Santa
Rosa, Calif ), 13 Zenith (Cook Diagnostic, Bloomington,
Ind), 2 Lifepath (Edwards Lifesciences LLC, Irvine, Calif ),
10 Powerlink (Endologix, Inc, Irvine, Calif ), 1 Excluder
(W.L. Gore and Assoc, Flagstaff, Ariz), 13 Talent (World
Medical Manufacturing Corp, Sunrise, Fla), 1 TriVascular
(TriVascular Inc, Santa Rosa, Calif ), and 3 with unknown
manufacturer. Of these, 19 (13 Zenith, 5 Powerlink, and 1
TriVascular) used suprarenal fixation.
Preoperative contrast-enhanced computed tomography
(CT) scans were obtained in all open and EVAR patients
using multidetector scanners (General Electric HISPEED
CTi or LightSpeed Qxi, GE Medical Systems, Milwaukee,
Wis). The three-phase CT angiogram (CTA) consisted of a
noncontrast scan through the lower chest and abdomen,
followed by a CTA using 120 mL of nonionic contrast. A
2-minute delayed CT scan was then performed again
through the lower chest and abdomen. EVAR patients were
followed-up with CTA at 1, 6, and 12 months and then
annually thereafter. Open patients had annual follow-up du-
plex scans. All contrast requiring imaging and procedures
performed after 2000 were pretreated with acetylcysteine,9
and those performed after 2004 were pretreated with acetyl-
cysteine and sodium bicarbonate solution.10
Patient data were collected in a retrospective manner
from hospital and office chart review. Baseline demographic
data were recorded, including age, gender, a history of to-
Table I. Patient characteristics
EVAR
n  52 (%)
Open
n  46 (%) P
Age (years) .0002
Mean 77.3  6.2 71.3  8.8
Range 62-90 36-84
Male gender 96.2 80.4 .022
Hypertension 89.1 81.3 .343
Diabetes mellitus 8.9 9.4 .999
Coronary artery disease 63 80.6 .13
Peripheral vascular disease 42.5 36.7 .806
Tobacco use (%) 80.5 87.5 .532
AAA size (mm) .522
Mean 57.4  9.9 58.7  9.4
Range 37-82 41-80
Operative time (min) 248  82 253  68 .768
Length of follow-up
(months) 15.6  14.7 19.8  19.8 .253
EVAR, Endovascular aneurysm repair; AAA, abdominal aortic aneurysm.
Data are in percentages or mean  SD and ranges.bacco use, diabetes mellitus, hypertension, coronary arterydisease, or peripheral vascular disease. For comparison of the
effects of open repair and EVAR on renal function, serum
creatinine (SCr) levels were recorded preoperatively, immedi-
ate postoperatively, and at the last follow-up. To compensate
for weight, age, and gender differences, creatinine clearances
(CrCl) were calculated using the Cockcroft-Gault formula,
CrCl  (140 – age)  weight/(SCr  72).11 The develop-
ment of postoperative renal impairment and the need for
hemodialysis was also recorded.
Baseline renal insufficiency was defined as a preopera-
tive serum creatinine 1.5 mg/dL. Renal impairment was
defined as an increase in serum creatinine 30% or the
newly acquired need for hemodialysis. Coronary artery
disease was defined as angina, myocardial infarction, or a
history of cardiac surgery. Peripheral vascular disease was
defined as claudication, rest pain, or a history of surgery for
arterial occlusive disease.
Data analysis. Data were expressed as mean  stan-
dard deviation where appropriate. Comparison of continu-
ous variables between groups was made using Student’s
t test for independent variables. Student’s t test was used for
comparisons within the open and EVAR groups over time.
Categoric variables were compared using the Fisher exact
test. Differences were considered significant if the two-
tailed P value was .05.
RESULTS
Demographics. The average age was significantly higher
in the EVAR group (77.3  6.2 years) than in the open
group (71.3  8.8 years) (P  .0002). In addition, the
percentage of men was significantly higher in the EVAR
group (96.2%) vs the open group (80.4%) (P  .022).
Preoperative aneurysm diameter, operative time, and the
prevalence of comorbid conditions were similar between
the groups (Table I). Mean intraoperative contrast admin-
istration was 134  69 mL during EVAR. In the open
group, mean cross-clamp time was 45 12 minutes. Mean
follow-up was 15.6  14.7 months for EVAR and 19.8 
19.8 months for open (P  .253).
Renal function. Baseline serum creatinine was similar
between both cohorts (Table II). Although serum creati-
nine increased in the EVAR group over time (preoperative,
2.04  0.55 mg/dL; postoperative, 2.27  1.04 mg/dL;
follow-up, 2.40  1.37 mg/dL) it failed to reach statistical
significance when the postoperative (P .091) and follow-up
(P  .081) levels were compared with preoperative levels
(Table III). In the open group, serum creatinine signifi-
cantly increased in the postoperative period (2.43  1.20
mg/dL) compared with preoperative levels (2.04  0.64
mg/dL, P  .012). During subsequent follow-up, how-
ever, serum creatinine returned to baseline (preoperative,
2.04  0.64 mg/dL; follow-up, 1.96  94 mg/dL; P 
.504). There were no statistically significant differences in
serum creatinine levels between the EVAR and open pa-
tients during the preoperative (P  .992), postoperative
(P  .479), or the follow-up (P  .100) periods (Fig, A).
A similar trend was noted in creatinine clearance,
with no statistically significant difference between EVAR
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operative (P  .517), or the follow-up (P  .065)
periods (Fig, B ). Likewise, although the preoperative,
postoperative, and follow-up creatinine clearance de-
creased in EVAR patients (39.0  12.9, 39.9  17.5,
and 37.2  17.1 mL/min, respectively) and increased in
the open group (39.2  16.2, 37.1  18.0, and 46.4 
22.5 mL/min, respectively) over time, this too failed to
reach statistical significance (Table III).
The absolute change in serum creatinine between the
postoperative and preoperative time periods was similar be-
tween groups (EVAR, 0.25  0.94 mg/dL; open, 0.39 
0.99mg/dL; P .479). When the absolute change in serum
creatinine between the follow-up and preoperative time peri-
ods was compared, there was a notable difference between
groups (EVAR, 0.37  1.36 mg/dL; open, –0.08  0.74
mg/dL); however, this difference failed to reach statistical
significance (P  .077).
Renal impairment developed in 15 EVAR (28.8%) and
13 open patients (28.3%), which was not statistically differ-
ent (P  .999) (Table II). To further examine the time
frame during which renal impairment developed, those
Table II. Renal outcomes
EVAR
n  52 (%)
Open
n  46 (%) P*
Serum creatinine (mg/dL)
Baseline 2.04  0.55 2.04  0.64 .992
Change
Pre-op vs post-op 0.25  0.94 0.39  0.99 .416
Pre-op vs follow-up 0.37  1.36 0.08  0.74 .077
Renal impairment†
Total 15 (28.8) 13 (28.3) .999
Post-op 9 (17.3) 11 (23.9) .46
Follow-up 13 (25.0) 5 (10.9) .12
Hemodialysis (%) 4 (7.7) 2 (4.3) .681
EVAR, Endovascular aneurysm repair.
Data presented as numbers (%) or mean  SD.
*Comparison between open and EVAR groups.
†Defined as elevation in serum creatinine by 30%.
Table III. Comparison of change in serum creatinine
and creatinine clearance over time
EVAR
n  52 P*
Open
n  46 P*
Serum creatinine (mg/dL)
Preoperative 2.04  0.55 2.04  0.64
Postoperative 2.27  1.04 .092 2.43  1.20 .012
Follow-up 2.40  1.37 .081 1.96  0.94 .504
Creatinine clearance (mL/min)
Preoperative 39.0  12.9 39.2  16.2
Postoperative 39.9  17.5 .789 37.1  18.0 .644
Follow-up 37.2  17.1 .599 46.4  22.5 .18
EVAR, Endovascular aneurysm repair.
Data are presented as mean  SD.
*Paired Student’s t test compared with preoperative values.patients whose renal impairment developed in the postop-erative period or follow-up periods were compared. In the
postoperative period, renal impairment was present in nine
EVAR (17.3%) and 11 open patients (23.9%) (P  .460).
During the follow-up period, eight of the 11 patients in the
open group recovered to baseline, and late renal impair-
ment developed in only two additional patients. In con-
trast, of the nine EVAR patients who had renal impairment
in the postoperative period, only two recovered, and renal
impairment developed in six additional patients during
follow-up.
Despite this different pattern of renal impairment after
aneurysm repair, there were no statistically significant dif-
ferences in renal impairment during follow-up in the EVAR
(25%) and open patients (10.9%) (P .120). Hemodialysis
was required in four EVAR patients (7.7%), one of which
was temporary. Two open patients (4.3%) required perma-
nent dialysis. These differences were not statistically signif-
icant (P  .681).
DISCUSSION
Endovascular abdominal aortic aneurysm repair has
become increasingly more common since its inception and
is rapidly becoming the predominant technique for repair
of infrarenal abdominal aortic aneurysm. Despite recent
studies that have confirmed the decreased perioperative risk
after EVAR compared with open repair,2,3 recent data have
suggested that issues remain regarding the durability and
long-term safety of EVAR.4,5
Of particular concern is the demonstration by several
investigators,7,12,13 and most recently by our group,8 of the
development of progressive renal dysfunction over time
after EVAR. Greenberg et al12 compared their experience
in 199 patients who underwent EVAR using the Zenith
suprarenal fixation device with 80 patients who had stan-
dard open repair. Although renal function did not differ
between groups during the perioperative period, the EVAR
patients did demonstrate a trend toward worsening renal
function over time.
Surowiec et al13 reviewed their results in 82 patients
after EVAR with a mean follow-up of 23 months and
compared them with 65 patients with open repair. Patients
who underwent EVAR with either suprarenal or infrarenal
fixation had similar serum creatinine levels, but both devel-
oped progressively worsening renal function over time,
which was significantly worse than open controls when
compared with patients with infrarenal fixation. Alsac et al7
published their data after EVAR in 277 patients and dem-
onstrated an approximate 10% decrease in calculated creat-
inine clearance within the first year after EVAR.
Most recently Parmer and Carpenter8 demonstrated a
similar trend with progressive renal dysfunction after EVAR
in 283 patients. In this study comparing the effects of
suprarenal or infrarenal fixation on renal function, serum
creatinine increased and calculated creatinine clearance sig-
nificantly decreased in both groups after EVAR. Further-
more, this elevation was persistent in those patients with
follow-up 12 months, suggesting either an ongoing ef-
fect from EVAR or follow-up contrast CTA on renal func-
erati
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erative renal insufficiency failed to demonstrate a statistical
difference between suprarenal and infrarenal fixation in the
development of renal impairment after EVAR.
In the current study, we compared the effect of EVAR
and open repair on renal function in patients with preexis-
tent renal insufficiency, a population particularly prone to
complications. Several findings in this analysis that deserve
further discussion.
Both patient populations were well matched for co-
morbid conditions and had similar aneurysm sizes and
operative times (Table I), but the EVAR patients were
significantly older than those with open repair. Although
this may impact the data, because older patients tend to be
more sensitive to renal insults, this finding is not surprising.
Especially during the early experience, EVAR was typically
reserved for the older, higher-risk patients. This trend is
becoming less common because younger patients are now
being treated with EVAR in increasing numbers.
In addition, the EVAR group included significantly
fewer women. This is consistent with previous data that
demonstrated that more than half of female patients fail to
be candidates for EVAR, whereas approximately 70% of
male patients qualify.14 Although with continued innova-
tion, EVAR devices and introduction sheaths are becoming
lower in profile, many women continue to not qualify owing
to access constraints from inadequate access vessel size.
Regarding renal function, this study failed to demon-
strate any significant difference between EVAR and open
patients with respect to changes in serum creatinine levels
(Fig, A) or creatinine clearance (Fig, B) after aneurysm
repair. There are, however, several interesting findings.
Although these differences failed to reach statistical signif-
icance, a clear difference emerged in the pattern of changes
in serum creatinine levels between groups.
In the open group, serum creatinine levels significantly
increased in the postoperative period, but the average level
returned over time to baseline (Table III). In contrast, the
Fig. Bar graphs compare mean serum creatinine (A) and
and endovascular aneurysm repair (EVAR) during preopEVAR group had a progressive increase in serum creatininelevels in the postoperative and follow-up periods compared
with preoperative levels, but these changes were not statis-
tically significant (Table III). A similar trend was noted
with respect to creatinine clearance in the open and EVAR
groups (Table III). When examining the proportion of
patients who developed significant renal impairment, de-
fined as a rise in serum creatinine levels 30%, further
insight into these differences can be seen.
During the immediate postoperative period, renal im-
pairment developed in 11 open patients (23.9%), and eight
(73%) recovered. Only an additional two patients devel-
oped late renal impairment, resulting in a renal impairment
rate of 10.9% during long-term follow-up after open repair.
From these data, it seems clear that despite the presence of
multiple comorbid conditions, most patients undergoing
open aneurysm repair are at greatest risk for renal impair-
ment in the immediate postoperative period.
Although all effort was made to minimize perioperative
renal insults, this likely represents the cumulative effect of
renal insults occurring at the time of surgery, including
ischemia during cross-clamping, embolic events, and hypo-
tension. Six (13%) of the 46 open patients had renal artery
stenosis; of these, two underwent bypass and three had
endarterectomy at the time of the aneurysm repair. In
addition, these patients are at higher risk than EVAR pa-
tients for developing postoperative hypotension, which
could further impact renal function. Interestingly, how-
ever, the effects on renal function in most are relatively
short lived and appear to be reversible.
In contrast, EVAR patients demonstrated a marked
difference in the pattern of changes in renal function.
Although renal impairment developed in only nine EVAR
patients (17.3%) in the immediate postoperative period,
only two (22%) recovered. During subsequent follow-up,
significant renal impairment developed in an additional six
EVAR patients, resulting in a follow-up rate of 25%, more
than twice that seen with open repair, although not statis-
tinine clearance (CrCl) (B) between patients with open
ve, postoperative, and follow-up time periods.creatically significant (P  .120).
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lower incidence of postoperative hypotension, renal impair-
ment during the immediate postoperative period likely
represents insults occurring intraoperatively. These causes
are likely multifactorial, including a combination of con-
trast, mechanical, and atheroembolic sources.15 These pa-
tients are routinely exposed to intravenous contrast dye
during CT or, less commonly, catheter angiography during
preoperative evaluation. Also, one of the 52 EVAR patients
had significant bilateral renal artery stenosis requiring stent
placement during aneurysm repair. Furthermore, during
placement, self-expanding grafts are often partially de-
ployed in the suprarenal position and pulled down the aorta
into the final position. This maneuver may potentially
dislodge aortic debris, resulting in atheroemboli into the
renal vessels, as evidenced by renal infarction rates as high as
19% during EVAR.16 Finally, many devices use balloon
fixation of the proximal graft, which may temporarily oc-
clude the renal vessels potentially resulting in thrombosis,
embolus, or dissection.
Perhaps more concerning is that those who develop
renal impairment seem to rarely recover after EVAR, and
in addition, increased numbers of patients having under-
gone EVAR seem to be at continued risk for renal
impairment during follow-up. This likely represents the
cumulative effect of repeated contrast exposure during
routine surveillance. This has been also suggested in
previous studies.8,13,17 Efforts to limit this effect include
the use of magnetic resonance angiography (MRA) or
duplex ultrasonography (DUS) as an alternative to CT
angiography and should be considered, especially in those
at high risk for developing contrast-induced nephropathy.
Furthermore, with further development of pressure sensing
devices, contrast-enhanced studies may be reduced or elim-
inated altogether. In the meantime, acetylcysteine9 and
sodium bicarbonate,10 alone or in combination, should be
used because they have been shown to decrease the inci-
dence of contrast-induced nephropathy.
CONCLUSION
Open and endovascular repair of abdominal aortic an-
eurysms in patients with pre-existent renal insufficiency can
be performed safely with preservation of renal function.
Although with limited numbers perhaps making this study
prone to a type II statistical error, in contrast to previous
reports, there were no significant differences between open
repair and EVAR in postoperative alterations in renal func-
tion. Perhaps more interesting, however, is the trend of
changes in renal function in patients with baseline renal
insufficiency that this study brings to light. Patients with
renal insufficiency have a significant increase in serum cre-
atinine levels postoperatively with open repair, but this
appears to be transient. After EVAR, patients with pre-
existing renal insufficiency continue to be at risk for pro-
gressive renal dysfunction, and protective measures should
be taken to preserve renal function in this patient popula-
tion. In short, preoperative renal dysfunction alone should
not exclude either approach.AUTHOR CONTRIBUTIONS
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